...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Can someone explain the Biogen situation to me....

"Biogen gave a presentation on aducanumab today which indicated that the result of the futility analysis based on data available as of 26 December 2018 “was incorrect”.

 

Share
New Message
Please login to post a reply